Wenbin Ou

17PUBLICATIONS
42CO-AUTHORS
Molecular targetsHaematological tumoursSolid tumoursMetabolic medicineCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 27, 2026
Correction: Song et al. AXL Inactivation Inhibits Mesothelioma Growth and Migration via Regulation of p53 Expression. Cancers 2020, 12, 2757.

|Sep 22, 2025
Novel Claudin18.2-Targeted Therapies in Gastrointestinal Tumors.

Wei Ye, Mengting Xu, Yijie Gu

|Apr 17, 2025
The activated tyrosine kinase ACK1 by multiple receptor tyrosine kinases promotes proliferation and invasion of mesothelioma via regulation of PI3K/AKT/mTOR and RAF/MAPK signaling pathways.

Yue Qiao, Shuihao Zhu, Zhenni Liu

|Feb 07, 2025
Genomic landscaping of receptor tyrosine kinase ALK with highly frequent rearrangements in cancers.

Wei Ye, Wen-Bin Ou

|Feb 26, 2024
KIT ATP-Binding Pocket/Activation Loop Mutations in GI Stromal Tumor: Emerging Mechanisms of Kinase Inhibitor Escape.

Thomas Mühlenberg, Johanna Falkenhorst, Tom Schulz

|Sep 29, 2023
Hyper-Dependence on NHEJ Enables Synergy between DNA-PK Inhibitors and Low-Dose Doxorubicin in Leiomyosarcoma.

Adrian Marino-Enriquez, Jan Philipp Novotny, Doga C Gulhan

Pageof 3

Frequent Collaborators

4 joint publications

Adrian Mariño-Enriquez

4 joint publications

Jonathan A Fletcher

2 joint publications

Suzanne George

2 joint publications

Meijun Z Lundberg